Gene therapy of pain: Emerging strategies and future directions

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 39-48

  Pohl, Michel ^a   Braz, Joao ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Gene therapy; Herpes simplex virus derived vector; Opioid peptide; Pain chronic

Indexed keywords

BETA ENDORPHIN; OPIATE PEPTIDE; PROENKEPHALIN; VIRUS VECTOR;

ANALGESIC ACTIVITY; CHRONIC PAIN; DRUG DESIGN; DRUG EFFECT; DRUG SAFETY; FEASIBILITY STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SENSORY NERVE CELL; TECHNIQUE;

ANIMALS; FORECASTING; GENE THERAPY; GENETIC VECTORS; HUMANS; PAIN;

EID: 0035840843     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01304-8     Document Type: Review

References (73)

1. Non-viral gene transfer: Applications in developmental biology and gene therapy
2. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle
3. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
4. Herpes simplex virus-1 mediated transfer of preproenkephalin A in rat dorsal root ganglia
5. Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats
6. Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis
7. + channels in pain pathways
8. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor
9. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene
10. Retrovirus-mediated expression of an artificial β-endorphin precursor in primary fibroblast
11. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus and retrovirus vectors
12. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucletotide reductase
13. Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience
14. Adeno-associated viral vectors for gene transfer and gene therapy
15. Pain-related disability and effects of chronic morphine in the adjuvant-induced arthritis model of chronic pain
16. Sensitization to morphine induced by viral-mediated gene transfer
17. Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats
18. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo
19. Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity
20. Cyclooxygenase inhibitors - Current status and future prospects
21. Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat
22. Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells supresses LPS induction of IL-6 and IL-10
23. Towards gene therapy for the central nervous system
24. Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies
25. Methionine-enkephalin in bone and joint tissues
26. A paracrine paradigm for in vivo gene therapy in the central nervous system: Treatment of chronic pain
27. Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons
28. + gated ion channel
29. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors
30. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
31. Intervention with spinal NMDA, adenosine, and NO systems for pain modulation
32. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve
33. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy
34. Gene therapy of chronic inflammatory disease
35. Specific regulation of gene expression by antisens, sense and antigene nucleic acids
36. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain related neurochemical reorganisation of the spinal cord
37. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs
38. High efficacy gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5
39. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
40. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: Part II. Vector systems and applications
41. Gene therapy for arthritis 1996-1999
42. Dix ans de thérapie génique: Déceptions et espoirs
43. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector
44. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
45. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides
46. Reduction in locomotor activity of arthritic rats as parameter for chronic pain: Effect of morphine, acetylsalicylic acid and citalopram
47. Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system
48. Polyethylenimines for in vivo gene delivery
49. Analysis of a multi-mutant herpes simplex virus type 1 for gene transfer into sympathetic preganglionic neurons and a comparison to adenovirus vectors
50. Chronic morphine reduces pain-related disability in a rodent model of chronic, inflammatory pain
51. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus
52. Long-term promoter activity during herpes simplex virus latency
53. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
54. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase
55. Experimental therapy of human glioma by means of genetically engineered virus mutant
56. The induction of pain: An integrative review
57. Development of optimized vectors for gene therapy
58. Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice
59. Relief of intractable cancer pain by human chromaffin cell transplants; experience at two medical centers
60. Enkephalinergic and dynorphinergic neurons in the spinal cord and dorsal root ganglia of the polyarthritic rat-in vivo release and cDNA hybridization studies
61. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses
62. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1
63. Gene transfer into neurones for the molecular analysis of behaviour: Focus on herpes simplex vectors
64. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
65. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
66. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation in mice
67. Cell vehicles for gene transfer to the brain
68. A proton gated cation channel involved in acid sensing
69. Translating stem and progenitor cell biology to the clinic: Barriers and opportunities
70. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus
71. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium
72. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo
73. Targeted gene correction: A new strategy for molecular medicine